Citation 103863

MC DOUGLAL,B: KING,PJ: WU,BW: HOSTOMSKY,Z: REINECKE,MG: ROBINSON JR,WE:. (1998). DICAFFEOYLQUINIC AND DICAFFEOYLTARTARIC ACIDS ARE SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE I INTEGRASE.. 42(1)

Citation Details

Title	DICAFFEOYLQUINIC AND DICAFFEOYLTARTARIC ACIDS ARE SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE I INTEGRASE.
Authors	MC DOUGLAL,B: KING,PJ: WU,BW: HOSTOMSKY,Z: REINECKE,MG: ROBINSON JR,WE:
Year	1998
Volume	42
Issue	1

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	INACTIVE
2	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	INACTIVE
4	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	INACTIVE
5	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	INACTIVE
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	INACTIVE
7	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	INACTIVE
8	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	INACTIVE
9	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	INACTIVE
10	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,1-5-DICAFFEOYL:	ACTIVE
11	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,1-5-DICAFFEOYL:	EQUIVOCAL
12	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,1-5-DICAFFEOYL:	EQUIVOCAL
13	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,1-5-DICAFFEOYL:	EQUIVOCAL
14	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,1-5-DICAFFEOYL:	ACTIVE
15	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL: 1-METHOXY:	WEAK ACTIVITY
16	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL: 1-METHOXY:	EQUIVOCAL
17	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL: 1-METHOXY:	WEAK ACTIVITY
18	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL: 1-METHOXY:	EQUIVOCAL
19	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL: 1-METHOXY:	ACTIVE
20	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL:	ACTIVE
21	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL:	EQUIVOCAL
22	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL:	WEAK ACTIVITY
23	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL:	EQUIVOCAL
24	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-5-DICAFFEOYL:	ACTIVE
25	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	ACTIVE
26	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	EQUIVOCAL
27	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	EQUIVOCAL
28	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	EQUIVOCAL
29	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	ACTIVE
30	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-DICAFFEOYL:	WEAK ACTIVITY
31	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-DICAFFEOYL:	EQUIVOCAL
32	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-DICAFFEOYL:	WEAK ACTIVITY
33	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-DICAFFEOYL:	EQUIVOCAL
34	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-DICAFFEOYL:	ACTIVE
35	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID	INACTIVE
36	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID	INACTIVE
37	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CICHORIC ACID,L:	ACTIVE
38	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CICHORIC ACID,L:	WEAK ACTIVITY
39	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CICHORIC ACID,L:	WEAK ACTIVITY
40	RNASE H INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CICHORIC ACID,L:	EQUIVOCAL
41	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CICHORIC ACID,L:	ACTIVE

Citation 103863

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1